CoDa Therapeutics Receives $10M

San Diego-based CoDa Therapeutics has received $10M in Series A financing, the firm reported this morning. Funding came from Domain Associates. CoDa Therapeutics is developing wound care treatments. CoDa said that it also anticipates the closing of an additional $5 to $10M in financing during the next 90 days. CoDa is headed by Bradford J. Duft, who was most recently an executive at Amylin Pharmaceuticals. The firm said that the funding would go towards IND enabling formulation and studies to permit the firm to complete Phase 1 safety and Phase 2 efficacy clinical trials. More information »